NZ Plans New Medicinal Cannabis Regulatory Scheme & Agency
Executive SummaryA new regulatory scheme for medicinal cannabis products, complete with a brand new agency, is on the cards in New Zealand, based on a strict licensing and quality control system that is intended to increase the supply of, and patient access to, such products.
You may also be interested in...
Drug Science, a UK charity, is about to launch a 20,000-patient pilot project looking at the use of medicinal cannabis for conditions like chronic pain, multiple sclerosis and Tourette’s syndrome. It says a special licensing status for such products could eventually be possible.
The Belgian authorities are taking steps to reduce the consumption of benzodiazepine-containing medicines, and have also reiterated the risks associated with the increasing use of opioid medications.